Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$114,982
-$18,875 QoQ
Shares Held
4,775
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,524
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacific Center for Financial Services holds $1,504,810 across 13 Drug Manufacturers - General names. PFE ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 3 | ABBV |
AbbVie Inc.
|
935 | $235,283 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,757 | $158,858 | |
| 5 | PFE |
Pfizer Inc
This page
|
4,775 | $114,982 | |
| 6 | AMGN |
Amgen Inc
|
264 | $95,599 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
612 | $77,320 | |
| 8 | AZN |
Astrazeneca PLC
|
175 | $33,183 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,982 | 4,775 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $133,857 | 4,767 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $112,124 | 4,503 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $114,736 | 4,503 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $108,958 | 4,495 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $113,725 | 4,488 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $118,880 | 4,481 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $129,506 | 4,475 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $125,042 | 4,469 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $120,407 | 4,339 | Shares | Sole | 2024-05-20 | |
| 2023-12-31 | $124,804 | 4,335 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $191,291 | 5,767 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $209,882 | 5,722 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $233,376 | 5,720 | Shares | Sole | 2023-05-16 | |
| 2022-09-30 | $257,571 | 5,886 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $323,597 | 6,172 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $295,658 | 5,711 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $355,776 | 6,025 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $255,909 | 5,950 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $220,784 | 5,638 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $211,728 | 5,844 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $206,062 | 5,598 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $207,171 | 5,645 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $184,526 | 5,643 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $184,121 | 5,641 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||